Triastek

RNA
#3D printing #BioNTech #Partnership #RNA Therapeutics #Triastek

BioNTech and Triastek team up to create 3D printed RNA therapeutics

BioNTech and Triastek have entered into a research collaboration and platform technology license agreement to develop RNA therapeutics for oral delivery based on 3D printing technology. The collaboration aims to provide groundbreaking therapies to address unmet medical needs in an easy to administer oral formulation. Read More

#Business & Investment #News

Gastrointestinal tract
#Drug delivery #Gastrointestinal #Precision medicine #Triastek

3D-printed oral treatment for ulcerative colitis proves successful

A first in human study of a 3D printing drug product, T21, designed to treat moderate to severe ulcerative colitis (UC), has reported positive results. Imaging results from the study confirmed that T21 tablets are precisely delivered and released to the target site (the colon) for… Read More

#News